---
figid: PMC9639034__JCMM-26-5379-g001
pmcid: PMC9639034
image_filename: JCMM-26-5379-g001.jpg
figure_link: /pmc/articles/PMC9639034/figure/jcmm17554-fig-0006/
number: FIGURE 6
figure_title: ''
caption: Significantly different signalling pathway between high‐ and low‐risk subgroups
  were obtained by GSEA
article_title: Establishment of a five‐enzalutamide‐resistance‐related‐gene‐based
  classifier for recurrence‐free survival predicting of prostate cancer.
citation: Jing Chen, et al. J Cell Mol Med. 2022 Nov;26(21):5379-5390.
year: '2022'

doi: 10.1111/jcmm.17554
journal_title: Journal of Cellular and Molecular Medicine
journal_nlm_ta: J Cell Mol Med
publisher_name: John Wiley and Sons Inc.

keywords:
- classifier
- enzalutamide
- prostate cancer
- recurrence‐free survival

---
